Endocrine Pathophysiology - USMLE Step 1

SECTION 1

Historical Context & Motivation

The study of endocrine pathophysiology emerged from centuries of clinical observation that certain diseases could not be explained by structural organ damage alone. Physicians recognized that chemical messengers circulating in the blood coordinated distant organ functions, and when these messengers were produced in excess or deficiency, stereotypical clinical syndromes resulted. The evolution of endocrinology from crude organ extracts to sophisticated molecular assays mirrors the broader trajectory of biomedical science, and understanding this history enriches your interpretation of the feedback loops and receptor-mediated signaling that underpin modern diagnosis and treatment.

1849 • Addison Describes Adrenal Insufficiency

Thomas Addison published his seminal monograph linking destruction of the adrenal glands to a fatal wasting syndrome characterized by hypotension, hyperpigmentation, and electrolyte derangement — the first clinically defined endocrine disease.

1902 • Bayliss & Starling Discover Secretin

Ernest Starling and William Bayliss demonstrated that secretin, released from the duodenal mucosa, stimulated pancreatic secretion even when all nerves were severed. Starling coined the term hormone (from Greek 'hormao,' to excite), establishing the concept of bloodborne chemical messengers.

1921 • Banting & Best Isolate Insulin

Frederick Banting and Charles Best isolated insulin from canine pancreatic extracts, transforming type 1 diabetes from a universally fatal condition to a manageable chronic disease and earning the 1923 Nobel Prize.

1956 • Yalow & Berson Develop the Radioimmunoassay

Rosalyn Yalow and Solomon Berson introduced the radioimmunoassay (RIA), enabling precise quantification of circulating hormones at picomolar concentrations and unlocking the diagnostic era of endocrinology.

1977 • Recombinant Human Insulin Produced

Herbert Boyer's team at Genentech used recombinant DNA technology to synthesize human insulin in E. coli, inaugurating the era of biosynthetic hormone replacement therapy.

These milestones reveal a central question that endocrine pathophysiology seeks to answer: how do disruptions in hormone synthesis, secretion, transport, receptor binding, and feedback regulation produce the clinical syndromes tested on USMLE Step 1? The remainder of this lesson systematically addresses that question across the major endocrine axes.

SECTION 2

Core Principles of Endocrine Dysfunction

Endocrine pathology can be organized around a small set of recurring mechanistic themes. Whether you are evaluating a patient with Graves disease or Addison disease, the same fundamental principles of hormone over- or under-production, receptor sensitivity, and feedback regulation apply. Mastering these principles allows you to reason through unfamiliar clinical scenarios rather than relying on rote memorization.

Negative Feedback Loops

Most endocrine axes operate via negative feedback: rising end-organ hormone levels suppress hypothalamic and pituitary trophic hormones. Disruption of this loop — whether by autonomous secretion, receptor defects, or exogenous hormone administration — is the unifying mechanism behind most endocrine diseases.

Primary vs. Secondary vs. Tertiary

Primary disorders originate in the end-organ gland. Secondary disorders arise from pituitary dysfunction. Tertiary disorders reflect hypothalamic pathology. Distinguishing among these three levels requires measuring both trophic and end-organ hormones.

Hormone Excess vs. Deficiency

Clinical syndromes map neatly to whether the hormone is present in excess (hyper-) or deficiency (hypo-). Each produces a mirror-image constellation of signs and symptoms that can be predicted from the hormone's normal physiology.

Receptor & Post-Receptor Defects

Hormone resistance syndromes (e.g., type 2 diabetes, pseudohypoparathyroidism) arise when adequate hormone is present but target tissues fail to respond, often due to receptor mutations or impaired signal transduction. Labs show elevated hormone levels with clinical features of deficiency.

Autoimmunity in Endocrine Disease

Autoimmune destruction (e.g., Hashimoto thyroiditis, type 1 diabetes) and autoimmune stimulation (e.g., Graves disease with TSI) are among the most common etiologies of endocrine pathology. The distinction between destructive and stimulatory antibodies is clinically critical.

✦

KEY TAKEAWAY

Think of the hypothalamic-pituitary-end organ axis like a thermostat system in a building. The hypothalamus is the thermostat sensor, the pituitary is the control unit that sends the 'heat on' or 'heat off' signal, and the end-organ gland is the furnace. If the furnace overheats on its own (primary hypersecretion), the thermostat reads 'too hot' and turns down the signal — so trophic hormone drops. If the furnace breaks (primary insufficiency), the thermostat reads 'too cold' and cranks the signal up — so trophic hormone rises. Knowing where the break occurs in the feedback loop tells you whether trophic hormones will be high or low, which is the key to answering USMLE questions on endocrine pathology.

SECTION 3

Visual Explanation — The Hypothalamic-Pituitary Axes

The diagram illustrates the three-tier hierarchy of hypothalamic-pituitary-end organ regulation. Solid downward arrows represent stimulatory signals, while dashed red upward curves represent negative feedback. The localization guide at the bottom summarizes the expected lab patterns for primary, secondary, and tertiary disorders.

The diagram above encapsulates the single most important framework for USMLE endocrine questions. When presented with a clinical vignette, your first task is to identify which axis is affected and at which level the pathology resides. A patient with fatigue, weight gain, and cold intolerance has clinical hypothyroidism — but the critical distinction lies in whether the TSH is elevated (suggesting primary thyroid failure) or depressed (suggesting secondary/tertiary insufficiency). This same logic applies across every axis: measure the trophic hormone and the end-organ hormone, then determine whether the feedback loop is intact.

SECTION 4

Mechanisms of Endocrine Pathology

Thyroid Axis Disorders

The hypothalamic-pituitary-thyroid (HPT) axis is among the most frequently tested endocrine axes on USMLE Step 1. Thyrotropin-releasing hormone (TRH) from the hypothalamus stimulates thyroid-stimulating hormone (TSH) release from anterior pituitary thyrotrophs, which in turn stimulates the thyroid gland to synthesize and secrete thyroxine (T₄) and triiodothyronine (T₃). T₄ is the predominant circulating form and is converted to the more active T₃ in peripheral tissues by deiodinases. Free T₃ and T₄ exert negative feedback on both the hypothalamus and pituitary, completing the loop.

Condition	TSH	Free T₄	Mechanism
Graves disease	↓ (suppressed)	↑	Thyroid-stimulating immunoglobulins (TSI) bind TSH receptor → autonomous T₄/T₃ production → TSH suppressed by negative feedback
Hashimoto thyroiditis	↑ (elevated)	↓	Anti-TPO / anti-thyroglobulin antibodies → lymphocytic destruction of follicular cells → T₄ falls → loss of negative feedback → TSH rises
Secondary hypothyroidism	↓ or inappropriately normal	↓	Pituitary adenoma, Sheehan syndrome, or other pituitary pathology → insufficient TSH → thyroid under-stimulated
Toxic adenoma	↓ (suppressed)	↑	Activating mutation in TSH receptor → constitutive T₄/T₃ production from a single nodule → TSH suppressed
TSH-secreting adenoma	↑ (inappropriately elevated)	↑	Pituitary adenoma autonomously secreting TSH → drives thyroid → T₄ rises but fails to suppress TSH

Thyroid axis disorders with expected lab findings

Adrenal Axis Disorders

The hypothalamic-pituitary-adrenal (HPA) axis governs cortisol production. Corticotropin-releasing hormone (CRH) drives adrenocorticotropic hormone (ACTH) secretion, which stimulates the adrenal cortex zona fasciculata to produce cortisol. Cortisol feeds back on both the hypothalamus and pituitary. In Cushing syndrome (cortisol excess), the differential diagnosis hinges on ACTH levels: ACTH-independent causes (e.g., adrenal adenoma) show suppressed ACTH, while ACTH-dependent causes (e.g., pituitary Cushing disease, ectopic ACTH from small cell lung carcinoma) show normal-to-elevated ACTH. In Addison disease (primary adrenal insufficiency), cortisol is low and ACTH is markedly elevated due to loss of negative feedback. Because ACTH shares a precursor molecule (pro-opiomelanocortin, POMC) with melanocyte-stimulating hormone (MSH), elevated ACTH in Addison disease classically causes hyperpigmentation — a finding absent in secondary adrenal insufficiency where ACTH is low.

Calcium & Parathyroid Axis

Calcium homeostasis involves the interplay of parathyroid hormone (PTH), vitamin D (calcitriol), and calcitonin. PTH is secreted by the parathyroid glands in response to low ionized calcium, and it acts to increase serum calcium through three mechanisms: enhanced osteoclastic bone resorption, increased renal calcium reabsorption, and stimulation of 1α-hydroxylase in the kidney (converting 25-hydroxyvitamin D to active 1,25-dihydroxyvitamin D). In primary hyperparathyroidism (typically a parathyroid adenoma), both PTH and calcium are elevated — a combination that should not exist under normal feedback. Conversely, in pseudohypoparathyroidism (type 1a, Albright hereditary osteodystrophy), PTH levels are elevated but target tissues are resistant to PTH due to a Gsα protein defect, resulting in hypocalcemia despite high PTH — a classic receptor-level pathology.

⚠

HIGH-YIELD DISTINCTION

Primary hyperparathyroidism: Ca²⁺ ↑, PTH ↑ (inappropriately). Malignancy-associated hypercalcemia (PTHrP): Ca²⁺ ↑, PTH ↓ (appropriately suppressed by hypercalcemia). Both present with hypercalcemia, but PTH distinguishes them immediately.

SECTION 5

Detailed Breakdown — Major Endocrine Disorders

Side-by-side comparison of the pathogenesis of type 1 diabetes mellitus (autoimmune β-cell destruction with absolute insulin deficiency) versus type 2 diabetes mellitus (insulin resistance progressing to relative insulin deficiency). Note the key laboratory distinguishing feature: C-peptide levels.

Pituitary Disorders

Pituitary pathology can produce either hormone excess (functioning adenomas) or hormone deficiency (non-functioning adenomas compressing normal tissue, or destructive processes like Sheehan syndrome). The most common functioning pituitary adenoma is a prolactinoma, which presents with galactorrhea and hypogonadism (amenorrhea in women, decreased libido/erectile dysfunction in men). Prolactin is unique among anterior pituitary hormones because it is under tonic inhibitory control by hypothalamic dopamine; thus, dopamine agonists (cabergoline, bromocriptine) are first-line treatment rather than surgery. Growth hormone-secreting adenomas cause gigantism (if before epiphyseal closure) or acromegaly (if after closure), diagnosed by elevated IGF-1 and failure of GH suppression on oral glucose tolerance test.

Adrenal Cortex Disorders

The adrenal cortex is organized into three zones: the zona glomerulosa (aldosterone), zona fasciculata (cortisol), and zona reticularis (androgens) — remember the mnemonic 'GFR' from outer to inner corresponds to 'Salt, Sugar, Sex.' Conn syndrome (primary hyperaldosteronism) causes hypertension, hypokalemia, and metabolic alkalosis; aldosterone is regulated primarily by the renin-angiotensin-aldosterone system (RAAS) rather than ACTH, which is why it is preserved in secondary adrenal insufficiency. Congenital adrenal hyperplasia (CAH) most commonly results from 21-hydroxylase deficiency, which blocks cortisol and aldosterone synthesis and shunts precursors toward androgen production, causing virilization and potentially salt-wasting crisis in neonates.

SECTION 6

Worked Example — Localizing an Endocrine Disorder

Consider the following clinical vignette, which is typical of USMLE Step 1 endocrine questions.

ℹ

CLINICAL VIGNETTE

A 35-year-old woman presents with a 6-month history of fatigue, weight gain (15 lb), constipation, cold intolerance, and dry skin. Physical examination reveals a diffusely enlarged, non-tender thyroid gland and delayed relaxation of deep tendon reflexes. Laboratory studies show: TSH 45 mIU/L (normal 0.4–4.0), free T₄ 0.3 ng/dL (normal 0.8–1.8), and positive anti-thyroid peroxidase (anti-TPO) antibodies. What is the most likely diagnosis and the pathological mechanism?

Systematic Approach to Endocrine Localization

1
Step 1 — Identify the Clinical Syndrome

The symptoms — fatigue, weight gain, constipation, cold intolerance, dry skin, and delayed DTR relaxation — are classic for hypothyroidism. These features reflect decreased metabolic rate due to insufficient thyroid hormone action on target tissues.

Clinical syndrome: Hypothyroidism
2
Step 2 — Determine the Level of the Lesion Using Lab Values

TSH is markedly elevated (45 mIU/L) while free T₄ is low (0.3 ng/dL). Elevated TSH indicates the pituitary is responding appropriately to low T₄ levels — it is 'trying' to stimulate the thyroid gland. This pattern means the problem is at the thyroid gland itself, not at the pituitary or hypothalamus.

Localization: Primary hypothyroidism (end-organ failure with intact feedback)
3
Step 3 — Identify the Etiology

The presence of anti-TPO antibodies, combined with a diffusely enlarged thyroid, points to autoimmune destruction of thyroid follicular cells. This is Hashimoto thyroiditis, the most common cause of hypothyroidism in iodine-sufficient regions. Histologically, you would expect to see dense lymphocytic infiltration with germinal center formation and Hürthle cell metaplasia.

Etiology: Hashimoto thyroiditis (chronic lymphocytic thyroiditis)
4
Step 4 — Confirm with the Feedback Model

Check: In primary hypothyroidism, T₄ is low → negative feedback on the pituitary is reduced → TSH rises. ✓ This is exactly what the lab values show. If TSH were low or normal in the setting of low T₄, we would suspect secondary (pituitary) or tertiary (hypothalamic) hypothyroidism instead.

Feedback check: Consistent with primary thyroid failure
5
Step 5 — Integrate Clinical and Pathological Features

The final answer: this patient has primary hypothyroidism due to Hashimoto thyroiditis. The mechanism is autoimmune (type IV hypersensitivity) destruction of thyroid follicular cells by cytotoxic T lymphocytes and anti-TPO antibodies, leading to decreased T₃/T₄ synthesis and compensatory TSH elevation. Treatment is levothyroxine (synthetic T₄) replacement with TSH monitoring.

Diagnosis: Hashimoto thyroiditis → Primary hypothyroidism → Treat with levothyroxine

SECTION 7

High-Yield Comparisons & Distinctions

USMLE Step 1 frequently tests your ability to distinguish between conditions that share superficial features but differ in underlying pathophysiology. The following tables highlight the most commonly tested comparisons in endocrine pathophysiology.

Feature	Graves Disease	Toxic Multinodular Goiter	Subacute (de Quervain) Thyroiditis
Mechanism	TSI (thyroid-stimulating immunoglobulin) activates TSH receptors	Multiple autonomously functioning nodules with activating TSH-R mutations	Viral inflammation → follicular destruction → preformed hormone release
RAIU Pattern	Diffusely increased uptake	Patchy 'hot' and 'cold' areas	Very low uptake (thyroid is leaking, not synthesizing)
Unique Features	Exophthalmos, pretibial myxedema, thyroid bruit	Older patients, enlarged nodular gland	Tender thyroid, jaw/ear pain, preceded by URI; self-limited
ESR	Normal	Normal	Markedly elevated

Hyperthyroidism differential: Three common causes

Feature	Cushing Disease	Ectopic ACTH	Adrenal Adenoma
ACTH Level	↑ (moderate)	↑↑ (very high)	↓ (suppressed)
High-dose dexamethasone	Cortisol suppresses (>50% reduction)	Cortisol does NOT suppress	Cortisol does NOT suppress
Source	Pituitary corticotroph adenoma	Most commonly small cell lung carcinoma	Autonomous cortisol-secreting adrenal tumor
Bilateral adrenal hyperplasia?	Yes (ACTH-driven)	Yes (ACTH-driven)	No — contralateral adrenal atrophies

Cushing syndrome differential by ACTH dependence

✦

KEY TAKEAWAY

When distinguishing between causes of the same endocrine syndrome, think like a detective following the chain of command. If the boss (hypothalamus/pituitary) is overriding the system, trophic hormones are elevated and the downstream gland enlarges bilaterally. If a rogue employee (autonomous gland tissue) is acting alone, trophic hormones are suppressed, and the rest of the system atrophies from disuse. The dexamethasone suppression test exploits this logic for Cushing syndrome: a pituitary adenoma retains partial feedback sensitivity and can be partially suppressed, whereas ectopic sources and autonomous adrenal tumors cannot.

SECTION 8

Connection to Advanced Endocrine Concepts

The fundamental feedback loop model extends into several advanced clinical and molecular domains that bridge USMLE Step 1 material with Step 2 CK and clinical practice. Understanding these connections deepens your mechanistic reasoning and prepares you for the more nuanced clinical decision-making required in later training.

Step 1 Concept	Advanced Extension	Clinical Relevance
Negative feedback (HPT axis)	Thyroid hormone resistance (TRβ mutation) — labs show elevated T₃/T₄ with unsuppressed TSH	Must distinguish from TSH-secreting adenoma; treatment differs dramatically
Autoimmune thyroid disease	Polyglandular autoimmune syndromes (APS type 1: AIRE mutation; APS type 2: associated with HLA-DR3/DR4)	Patients with one autoimmune endocrinopathy should be screened for others
Insulin signaling & diabetes	MODY (maturity-onset diabetes of the young) — monogenic defects in β-cell function (e.g., glucokinase, HNF1α mutations)	Autosomal dominant inheritance; does not require insulin initially; often misdiagnosed as T1DM or T2DM
MEN syndromes	MEN1 (menin), MEN2A/2B (RET proto-oncogene) — familial neoplasia affecting multiple endocrine glands	Prophylactic thyroidectomy for MEN2 carriers; genetic counseling for families
Pheochromocytoma (adrenal medulla)	Paraganglioma syndromes (SDH mutations), Von Hippel-Lindau, NF1 — genetic testing now standard	Must alpha-block before beta-block to avoid hypertensive crisis during surgery

Step 1 foundations and their advanced clinical extensions

A particularly high-yield connection for board examinations is the relationship between the multiple endocrine neoplasia (MEN) syndromes and their molecular genetics. MEN1 (the '3 P's' — parathyroid hyperplasia, pituitary adenoma, pancreatic islet tumors) results from loss-of-function mutations in the menin tumor suppressor gene on chromosome 11q13. MEN2A (medullary thyroid carcinoma, pheochromocytoma, parathyroid hyperplasia) and MEN2B (medullary thyroid carcinoma, pheochromocytoma, mucosal neuromas, marfanoid habitus) result from gain-of-function mutations in the RET proto-oncogene. The distinction between loss-of-function (tumor suppressor) and gain-of-function (proto-oncogene) mechanisms maps directly onto fundamental concepts in cancer biology.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A patient has low serum cortisol, low ACTH, and low CRH levels. She reports having taken high-dose prednisone for 8 months for lupus nephritis. Explain why all three hormone levels are depressed and predict what would happen if prednisone were abruptly discontinued.

Show answer

Chronic exogenous glucocorticoid (prednisone) administration suppresses the HPA axis at every level through sustained negative feedback. CRH secretion from the hypothalamus decreases, which in turn reduces ACTH release from the pituitary, leading to adrenal cortex atrophy (particularly the zona fasciculata). All three levels — CRH, ACTH, and cortisol — are therefore low because the exogenous glucocorticoid satisfies the feedback sensor. If prednisone is abruptly discontinued, the atrophied adrenal glands cannot immediately resume cortisol production, and the suppressed hypothalamus/pituitary cannot rapidly upregulate CRH/ACTH. This creates a life-threatening adrenal crisis (tertiary adrenal insufficiency). Glucocorticoids must therefore be tapered gradually to allow HPA axis recovery.

Question 2: BASIC CALCULATION

A patient's labs show serum calcium of 11.8 mg/dL (normal 8.5–10.5) and PTH of 120 pg/mL (normal 10–65). Serum phosphate is 2.1 mg/dL (normal 2.5–4.5). Classify this as primary, secondary, or tertiary hyperparathyroidism, and explain the expected phosphate level.

Show answer

The combination of elevated calcium (11.8 mg/dL) with inappropriately elevated PTH (120 pg/mL) is diagnostic of primary hyperparathyroidism. Under normal feedback, hypercalcemia should suppress PTH via the calcium-sensing receptor (CaSR) on parathyroid chief cells. The fact that PTH remains elevated indicates autonomous PTH secretion, most commonly from a parathyroid adenoma (~85% of cases). The low phosphate (2.1 mg/dL) is expected because PTH decreases renal phosphate reabsorption by downregulating the sodium-phosphate cotransporter (NaPi-IIa) in the proximal convoluted tubule. In secondary hyperparathyroidism (e.g., chronic kidney disease), calcium would be low or normal and PTH elevated as a compensatory response.

Question 3: INTERMEDIATE

A 28-year-old woman presents with amenorrhea, galactorrhea, and visual field deficits (bitemporal hemianopsia). MRI reveals a 2.5-cm pituitary mass. Prolactin level is 250 ng/mL (normal < 25). What is the diagnosis, why does bitemporal hemianopsia occur, and what is the first-line treatment? How would you differentiate this from the 'stalk effect'?

Show answer

This presentation is classic for a prolactinoma (lactotroph adenoma), the most common functioning pituitary adenoma. The 2.5-cm size classifies it as a macroadenoma (>1 cm). Bitemporal hemianopsia occurs because the pituitary sits in the sella turcica directly below the optic chiasm; a superiorly expanding macroadenoma compresses the crossing nasal retinal fibers, producing bilateral temporal visual field loss. First-line treatment is a dopamine agonist (cabergoline preferred for efficacy and tolerability), not surgery, because prolactin secretion is tonically inhibited by hypothalamic dopamine. The 'stalk effect' refers to mild hyperprolactinemia (typically < 100–150 ng/mL) caused by any sellar mass compressing the pituitary stalk, thereby interrupting dopamine delivery to lactotrophs. The key distinction: in stalk effect, prolactin is mildly elevated; in a true prolactinoma, prolactin correlates with tumor size (large tumors → very high prolactin, often > 200 ng/mL).

Question 4: APPLIED

A 45-year-old man presents with episodic headaches, diaphoresis, palpitations, and blood pressure of 220/120 mmHg. 24-hour urine metanephrines and catecholamines are markedly elevated. CT abdomen reveals a 4-cm right adrenal mass. You suspect pheochromocytoma. Outline the preoperative pharmacologic management, explaining why the order of drug administration matters.

Show answer

The preoperative management of pheochromocytoma requires a specific sequence of alpha-blockade followed by beta-blockade. First, administer an irreversible alpha-1 antagonist (phenoxybenzamine) or a selective alpha-1 blocker (doxazosin) for at least 10–14 days preoperatively to control hypertension and expand the contracted intravascular volume. Only after adequate alpha-blockade should a beta-blocker (propranolol or atenolol) be added if tachycardia persists. The order is critical because catecholamines stimulate both alpha (vasoconstriction) and beta-2 (vasodilation) receptors. If a beta-blocker is given first, it eliminates the beta-2-mediated vasodilation, leaving alpha-mediated vasoconstriction unopposed, which can precipitate a life-threatening hypertensive crisis. The mnemonic is 'alpha before beta' — always block alpha receptors first.

Question 5: CRITICAL THINKING

A newborn female presents with ambiguous genitalia, hyponatremia (Na⁺ 125 mEq/L), hyperkalemia (K⁺ 6.8 mEq/L), and hypotension. 17-hydroxyprogesterone levels are markedly elevated, and ACTH is high. Cortisol and aldosterone are both low. Explain the complete pathophysiologic cascade, identify the enzyme deficiency, and discuss why ACTH is elevated despite the presence of elevated steroid precursors.

Show answer

This presentation is classic for salt-wasting congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, the most common form of CAH (>90% of cases). The enzyme 21-hydroxylase converts 17-hydroxyprogesterone to 11-deoxycortisol (cortisol pathway) and progesterone to 11-deoxycorticosterone (aldosterone pathway). Its deficiency blocks both cortisol and aldosterone synthesis, explaining the low cortisol and aldosterone and the resultant hyponatremia, hyperkalemia, and hypotension (aldosterone normally promotes Na⁺ reabsorption and K⁺ secretion in the collecting duct). With cortisol low, negative feedback on the hypothalamus/pituitary is lost, so ACTH rises dramatically. The elevated ACTH drives the adrenal cortex to overproduce steroid precursors upstream of the enzymatic block — hence the markedly elevated 17-hydroxyprogesterone. Critically, these precursors are shunted toward the androgen synthesis pathway (which does not require 21-hydroxylase), leading to excess dehydroepiandrosterone (DHEA) and androstenedione, which are peripherally converted to testosterone. This excess androgen exposure in utero causes virilization of the external genitalia in 46,XX females (ambiguous genitalia). ACTH is elevated despite high steroid precursors because the hypothalamic-pituitary feedback sensor specifically detects cortisol, not upstream intermediates. The precursors cannot substitute for cortisol in completing the negative feedback loop.

SUMMARY

Endocrine Pathophysiology — Summary

Summary

Endocrine pathophysiology is organized around hypothalamic-pituitary-end organ feedback axes that regulate hormone production through negative feedback. Disorders are classified as primary (end-organ gland pathology with elevated trophic hormones), secondary (pituitary dysfunction with low trophic and end-organ hormones), or tertiary (hypothalamic dysfunction). Key high-yield conditions include Graves disease (TSI-mediated hyperthyroidism with diffuse uptake on RAIU), Hashimoto thyroiditis (anti-TPO-mediated hypothyroidism, most common cause in iodine-sufficient areas), Cushing syndrome (differentiated by ACTH dependence and dexamethasone suppression), and Addison disease (primary adrenal insufficiency with hyperpigmentation from elevated ACTH/MSH).

Diabetes mellitus is distinguished by C-peptide levels (low in type 1, normal/high in type 2) and pathogenesis (autoimmune β-cell destruction versus insulin resistance with progressive β-cell failure). Pituitary adenomas are classified by functionality, with prolactinomas being most common and uniquely treated with dopamine agonists. The MEN syndromes (MEN1 with menin, MEN2 with RET) connect endocrine pathology to cancer genetics. For every endocrine question, your systematic approach should be: identify the clinical syndrome, measure trophic and end-organ hormones, localize the lesion within the feedback axis, and then determine the specific etiology.